Ignite Creation Date:
2024-05-06 @ 7:55 AM
Last Modification Date:
2024-10-26 @ 11:53 AM
Study NCT ID:
NCT02626507
Status:
UNKNOWN
Last Update Posted:
2022-02-09
First Post:
2015-12-07
Brief Title:
Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ERHER2- Breast Cancer
Sponsor:
Hoffman Oncology
Organization:
Hoffman Oncology
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-03-15
Completion Date Type:
ESTIMATED
First Submit Date:
2015-12-07
First Submit QC Date:
December 8 2015
Study First Post Date:
2015-12-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-25
Last Update Post Date:
2022-02-09
Last Update Post Date Type:
ACTUAL